Recombinant Mouse IL-17A Protein, C-His Tag
-
产品编号
KRP469
-
别名
白细胞介素17A, Interleukin-17A , IL-17, IL-17A, Cytotoxic T-lymphocyte-associated antigen 8, CTLA-8, Ctla8, Il17, Interleukin-17A
-
规格
- 20ug
- 50ug
- 100ug
- 200ug
- 1mg
| Catalog Number | KRP469 |
| Alias | 白细胞介素17A, Interleukin-17A , IL-17, IL-17A, Cytotoxic T-lymphocyte-associated antigen 8, CTLA-8, Ctla8, Il17, Interleukin-17A |
| Size | 20ug, 50ug, 100ug, 200ug, 1mg |
| Product Description | Mouse Il17a(26-158 aa) |
| Molecular Name | Il17a |
| Product Introduction | 白细胞介素17A通过调节免疫反应,参与抗肿瘤免疫反应。。 |
| Molecular Weight | 16-24 kDa |
| Expression System | HEK293F Cells |
| Species | Mouse |
| Concentration | 联系销售经理获得最新批次的浓度 |
| Purity | ≥95% |
| SDS-PAGE | ![]() |
| Purification | Affinity Purification |
| Uniprot ID | Q62386 |
| Storage Condition | Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles. |
| Formulation | Supplied in PBS |
| Shipping Condition | This product is shipped on ice packs or dry ice. |
| Background | Effector cytokine of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity (PubMed:18025225, PubMed:19144317, PubMed:26431948). Signals via IL17RA-IL17RC heterodimeric receptor complex, triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter. This leads to downstream TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways ultimately resulting in transcriptional activation of cytokines, chemokines, antimicrobial peptides and matrix metalloproteinases, with potential strong immune inflammation (PubMed:16200068, PubMed:17911633, PubMed:19144317, PubMed:26431948). Plays an important role in connecting T cell-mediated adaptive immunity and acute inflammatory response to destroy extracellular bacteria and fungi. As a signature effector cytokine of T-helper 17 cells (Th17), primarily induces neutrophil activation and recruitment at infection and inflammatory sites (PubMed:18025225). In airway epithelium, mediates neutrophil chemotaxis via induction of CXCL1 and CXCL5 chemokines (PubMed:18025225, PubMed:27923703). In secondary lymphoid organs, contributes to germinal center formation by regulating the chemotactic response of B cells to CXCL12 and CXCL13, enhancing retention of B cells within the germinal centers, B cell somatic hypermutation rate and selection toward plasma cells (PubMed:18157131). Effector cytokine of a subset of gamma-delta T cells that functions as part of an inflammatory circuit downstream IL1B, TLR2 and IL23A-IL12B to promote neutrophil recruitment for efficient bacterial clearance (PubMed:17372004, PubMed:20364087, PubMed:28709803). Effector cytokine of innate immune cells including invariant natural killer cell (iNKT) and group 3 innate lymphoid cells that mediate initial neutrophilic inflammation (PubMed:17470641, PubMed:23255360). Involved in the maintenance of the integrity of epithelial barriers during homeostasis and pathogen infection. Upon acute injury, has a direct role in epithelial barrier formation by regulating OCLN localization and tight junction biogenesis (PubMed:26431948). As part of the mucosal immune response induced by commensal bacteria, enhances host's ability to resist pathogenic bacterial and fungal infections by promoting neutrophil recruitment and antimicrobial peptides release (PubMed:28709803). In synergy with IL17F, mediates the production of antimicrobial beta-defensins DEFB1, DEFB103A, and DEFB104A by mucosal epithelial cells, limiting the entry of microbes through the epithelial barriers (PubMed:19144317). Involved in antiviral host defense through various mechanisms (PubMed:21946434, PubMed:26735852, PubMed:27795421). Enhances immunity against West Nile virus by promoting T cell cytotoxicity (PubMed:27795421). May play a beneficial role in influenza A virus (H5N1) infection by enhancing B cell recruitment and immune response in the lung (PubMed:21946434). Contributes to influenza A virus (H1N1) clearance by driving the differentiation of B-1a B cells, providing for production of virus-specific IgM antibodies at first line of host defense (PubMed:26735852). {ECO:0000269|PubMed:16200068, ECO:0000269|PubMed:17372004, ECO:0000269|PubMed:17470641, ECO:0000269|PubMed:17911633, ECO:0000269|PubMed:18025225, ECO:0000269|PubMed:18157131, ECO:0000269|PubMed:19144317, ECO:0000269|PubMed:20364087, ECO:0000269|PubMed:21946434, ECO:0000269|PubMed:23255360, ECO:0000269|PubMed:26431948, ECO:0000269|PubMed:26735852, ECO:0000269|PubMed:27795421, ECO:0000269|PubMed:27923703, ECO:0000269|PubMed:28709803}. |
| Endotoxin | < 0.1 EU per ug |
| Biological Activity | Immobilized Mouse IL- 17A/CTLA-8 at 2 μg/mL (100 μL/well) can bind Mouse IL- 17RA/CD217 with a linearrange of 0.1-26 ng/mL. |
| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 |
0